藥物成份

共有 21645 個藥物成份

Mitoxantrone Hydrochloride contains not less than 97.0% and not more than 102.0% of C22H28N4O6‧2HCl, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Moclobemide contains not less than 99.0 % and not more than 101.0 % of C13H17ClN2O2, calculated on the dried substance.

• 關聯藥證數量: 1

Modafinil contains not less than 98.0 percent and not more than 101.5 percent of C15H15NO2S, calculated on the dried basis.

• 關聯藥證數量: 1

Modafinil contains not less than 98.0 percent and not more than 102.0 percent of C15H15NO2S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Modified Lius Stain A\n- Methyl Alcohol，Methylen Blue，Eosin Y\nModified Lius Stain B\n- Azure II，Methylen Blue，KH2PO4，NA2HPO4，H2O\n

• 關聯藥證數量: 1

Molybdate Reagent:10 mmol/L sodium molybdate and non-reactive Surfactants and stabilizers. Phosphorus Catalyst:149 mmol/L ascorbic acid and non-reactive stabilizers.

• 關聯藥證數量: 1

Mometasone Furoate contains NLT 97.0% and NMT 102.0% of mometasone Furoate (C27H30Cl2O6), calculated on the dried basis.

• 關聯藥證數量: 1

Mometasone Furoate contains 97.0%~102.0% of C27H30Cl2O6, calculated on the dried basis.

• 關聯藥證數量: 1

Mometasone Furoate contains not less than 97.0 percent and not more than 102.0 percent of C27H30Cl2O6, calculated on the dried basis.

• 關聯藥證數量: 1

Mometasone Furoate contains not less than 97.0% and not more than 102.0% of C27H30CI2O6 calculated on the dried substance.

• 關聯藥證數量: 1

Mometasone Furoate contains not less than 97.0% and not more than 102.0% of C27H30Cl2O6 calculated on the dried basis.

• 關聯藥證數量: 1

Mometasone Furoate contains not less than 97.0% and not more than 102.0% of C27H30Cl2O6, calculated on the dried basis.

• 關聯藥證數量: 1

Mometasone Furoate contains not less than 97.0% and not more than 102.0% of C27H30Cl2O6, calculated on the dried basis.

• 關聯藥證數量: 1

Mometasone Furoate contains not less than 97.0% and not more than 103% of C27H30Cl2O6, calculated on dried substance.

• 關聯藥證數量: 1

Mometasone Furoate contains not less than 97.0% and not more than the equivalent to 103.0% of C16H22N2O6S, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Mometasone Furoate contains not less than 98.0% and not more than 102.0% of C27H30Cl2O6, calculated on the dried substance.

• 關聯藥證數量: 1

Monoammonium Glycyrrhizinate contains not less than 83.0% of Glycyrrhizic acid (C42H62O16), calculated on the dried basis.

• 關聯藥證數量: 1

Monobasic Sodium Phosphate Anhydrous It contains not less than 98.0% and not more than 103.0%, calculated on the dried basis.

• 關聯藥證數量: 1

Monobasic Sodium Phosphate Anhydrous contains not less than 98.0 percent and not more than 103.0 percent of NaH2PO4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Monobasic Sodium Phosphate Monohydrate (Sodium Hydrogen Phosphate Monohydrate) It contains not less than 98.0% and not more than 103.0%, calculated on the dried basis.

• 關聯藥證數量: 1

Monobasic Sodium Phosphate Monohydrate contains not less than 98.0 per cent and not more than 103.0 per cent of NaH2PO4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Monobasic Sodium Phosphate contains not less than 98.0% and not more than 103.0% of NaH2PO4‧H2O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Monobasic Sodium Phosphate is contains one molecules of water of hydration. It contains NLT 98.0% and NMT 103% of NaH2PO4 Calculated on the dried basis.

• 關聯藥證數量: 1

Monoclonal Antibody (mouse): 7 mL\nParticle Bound Acetaminophen: 4.8 mL

• 關聯藥證數量: 1

Monoclonal IgM-anitbodies, liquid.Preservative: < 0.1% NaN3.

• 關聯藥證數量: 1

Monoclonal IgM-anitbodies, liquid.\nPreservative: < 0.1% NaN3.

• 關聯藥證數量: 1

Monoclonal IgM-anitbodies, liquid.\nPreservative: < 0.1% NaN3.\n

• 關聯藥證數量: 1

Monoclonal Mouse antibody provided in liquid form as tissue culture supernatant in 0.05 mol/L Tris-HCl, pH 7.2 and 0.015 mol/L sodium azide, stabilizing protein.

• 關聯藥證數量: 1

Monoclonal anti-Barbiturates Antibody (mouse) 69mL\nGlucose-6-Phosphate Dehydrogenase labeled with barbiturates 18mL

• 關聯藥證數量: 1

Monoclonal antibodies (mouse hybridoma), liquid, Preservative: < 0.1% NaN3.

• 關聯藥證數量: 1

Monoclonal antibodies (mouse hybridoma), liquid, \nPreservative: < 0.1% NaN3.

• 關聯藥證數量: 1

Monoclonal antibodies (mouse hybridomas), Preservative: < 0.1% NaN3.

• 關聯藥證數量: 1

Monoclonal antibodies (mouse hybridomas), \nPreservative: < 0.1% NaN3.

• 關聯藥證數量: 1

Monospecific anti-human IgG is prepared by immunsing goats with purified Fc fragments of human IgG.\nThis product is also supplied as a green coloured reagent.

• 關聯藥證數量: 1

Montelukast Sodium 98.0%~102.0% (anhydrous basis)

• 關聯藥證數量: 1

Montelukast Sodium 98.0~102.0%

• 關聯藥證數量: 1

Montelukast Sodium contains Not Less Than 98.0% and Not More Than 102.0% of C35H35ClNNaO3S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Montelukast Sodium contains not less than 98.0% and not more than 102.0% of C35H35ClNNaO3S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Montelukast Sodium contains not less than 98.0% w/w and not more than 102.0% w/w, calculated on anhydrous basis.

• 關聯藥證數量: 1

Montelukast Sodium contains：98.0% to 102.0% (anhydrous substance).

• 關聯藥證數量: 1

Montmorillonite contains 55.0%~65.0% of Silicon Dioxide (SiO2) and 12.0%~25.0% of Aluminum oxide (Al2O3), calculated on dried basis.

• 關聯藥證數量: 1

Morphine HCL contains not less than 98.0 percent and not more than 102.0 percent of C17H20ClNO3‧3H2O, calculated on the dried basis.

• 關聯藥證數量: 1

Morphine Hydrochloride contains 98.0%~102.0% of C17H19NO3‧HCl‧3H2O, calculated on dried basis.

• 關聯藥證數量: 1

Morphine Sulfate contains 98.0%~102.0% of (C17H19NO3)2‧H2SO4‧5H2O, calculated on dried basis.

• 關聯藥證數量: 1

Morphine Sulfate contains 98.0% to 102.0% of Morphine Sulfate(C34H40N2O10S‧5H2O), calculated on the anhydrous substance.

• 關聯藥證數量: 1

Morphine Sulfate contains not less than 98.0 percent and not more than 102.0 percent of C34H40N2O10S, 5H2O, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Morphine sulfate contains not less than 98.0% and not more than 102.0% of C34H40N2O10S‧5H2O, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Mosapride Citrate Dihydrate contains not less than 98.0% and not more than the equivalent of 101.5% C21H25ClFN3O3, C6H8O7, 2H2O calculated on anhydrous basis.

• 關聯藥證數量: 1

Mosapride Citrate Dihydrate contains not less than 98.0 percent not more than 101.5 percent of C21H25ClFN3O3*C6H8O7*2H2O calculated on the dried basis.

• 關聯藥證數量: 1

Mosapride Citrate Dihydrate contains not less than 98.5 percent not more than 101.0 percent of C21H25C1FN3O3‧C6H8O7‧2H2O, calculated on the dried basis.

• 關聯藥證數量: 1

Mounting Medium\n？Buffered glycerol\n？Anti-Quencher

• 關聯藥證數量: 1

Mouse anti-Actin Antibody is from mouse ascites and diluted in phosphate buffered saline (PBS), pH7.4, and 1% bovine serum albium (BSA) with 0.1% sodium azide (NaN3) as preservative.

• 關聯藥證數量: 1

Mouse anti-BCL-10 Antibody is purified from mouse ascites and diluted in phosphate buffered saline (PBS), pH7.4,and 1% bovine serum albumin (BSA) with 0.1% sodium azide (NaN3) as a preservative.

• 關聯藥證數量: 1

Mouse anti-Collagen IV is mouse ascites diluted in phosphate buffered saline (PBS), and 1% bovine serum albumin (BSA) with 0.1% sodium azide (NaN3) as a preservative.

• 關聯藥證數量: 1

Mouse anti-E-Cadherin is purified from mouse ascites and diluted in phosphate buffered saline (PBS), pH 7.4, and 1% bovine serum albumin(BSA) with 0.1% sodium azide (NaN3) as a preservative.

• 關聯藥證數量: 1

Mouse anti-GFAP is purified from mouse ascites and diluted in phosphate buffered saline (PBS), pH 7.4, and 1% bovine serum albumin (BSA) with 0.05% sodium azide (NaN3) as a preservative.

• 關聯藥證數量: 1

Mouse anti-Human Kappa Light Chain is purified from mouse ascites and diluted in phosphate buffered saline (PBS), pH 7.4, and 1% bovine serum albumin (BSA) with 0.05% sodium azide (NaN3) as a preservative.

• 關聯藥證數量: 1

Mouse anti-Human Lambda Light Chain is purified from mouse ascites and diluted in phosphate buffered saline (PBS), pH 7.4, and 0.1% bovine serum albumin (BSA) with 0.05% sodium azide (NaN3) as a preservative.\n\n

• 關聯藥證數量: 1

Mouse anti-NSE is purified from mouse ascites and diluted in phosphate buffered saline (PBS), pH7.4, and 1% bovine serum albumin (BSA) with 0.1% sodium azide (NaN3) as a preservative.

• 關聯藥證數量: 1

Mouse anti-Vimentin is purified from mouse antisera and diluted in phosphate buffered saline (PBS), pH7.4, and 1% bovine serum albium (BSA) with 0.1% sodium azide (NaN3) as preservative.

• 關聯藥證數量: 1

Moxifloxacin Hydrochloride contains 98.0%~102.0% of C21H25ClFN3O4.(Calculated on anhydrous basis).

• 關聯藥證數量: 1

Moxifloxacin Hydrochloride contains not less than 98.0% and not more than 102.0% of C12H24FN3O4·HCL·H2O, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Moxifloxacin Hydrochloride contains not less than 98.0% and not more than 102.0% of C21H24FN3O4.HCl.H2O on anhydrous basis.

• 關聯藥證數量: 1

Moxifloxacin Hydrochloride contains not less than 98.0% and not more than 102.0% of C21H24FN3O4MCl, calculated on anhydrous substance.

• 關聯藥證數量: 1

Moxifloxacin Hydrochloride contains not less than 98.0% and not more than 102.0% of C21H25ClFN3O4, calculated on the anhydrous substance.

• 關聯藥證數量: 1

MsIgG1-RD1: The concentration of nonantibody reagentsis 0.2% BSA, 0.01 M potassium phosphate, 0.15 M NaCl, 0.1% NaN3 and stabilizers.

• 關聯藥證數量: 1

MsIgM-FITC: The final concentration of nonantibody reagents when reconstituted is 0.2% gelatin, 0.01 M potassium phosphate, 0.15 M NaCl.\nAntibody:\nSpecificity: Non Applicable \nClone: R4A3-22-12\nHybridoma: Sp2/0-AG14*BALB/c\nImmunogen : Non Applicable\nIg chain: IgM\nSpecies: Mouse\nSource: Conditioned media\nPurification: Gel filtration chromatography\nFluorescence: Excites at 468-509nm/Emits at 504-541nm\nConjugation: FITC (Fluorescein isothiocyanate)\nMolar Ratio: FITC/Protein: 3-10

• 關聯藥證數量: 1

Mueller Hinton Agar with 6ug/ml Oxacillin and 4% NaCL

• 關聯藥證數量: 1

Muleller Hinton II Agar (#221275, #221800)\nApproximate Formula* Per Liter Purified Water\nBeef Extract……………………………2 g\nAcid Hydrolysate of Casein………...17.5 g\nStarch…………………………………1.5 g\nAgar……………………………………17 g\nMueller Hinton II Agar with 5% Sheep Blood (#221801)\nMueller Hinton II Agar one liter with 5% Sheep Blood.\n

• 關聯藥證數量: 1

Multi Calibrator Lipids contains human serum (4 bottles x for 3 mL)

• 關聯藥證數量: 1

Multiconstituent Calibrator is prepared from a human-based matrix containing the following analytes: albumin, total protein (made from human sourced albumin material), calcium, creatinine, glucose, phosphorus, urea nitrogen, uric acid, cholesterol, and triglycerides.

• 關聯藥證數量: 1

Mumps Virus Coated Wells (IgG): 12 breakapart 8-well snap-off strips coated with MumpsVirus antigen. IgM Sample Diluent: 1 bottle containing 100 ml of buffer for sample dilution.Stop Solution: 1 bottle containing 15 ml sulphuric acid, 0.2 mol/l.Washing Solution (20x conc.): 1 bottle containing 50 ml of a 20-fold concentrated buffer. Mumps Virus anti-IgG Conjugate: 1 bottle containing 20 ml of a peroxidase labeled rabbit antibody to human IgG.TMB Substrate Solution: 1 bottle containing 15 ml TMB.Mumps Virus IgG Positive Control: 2ml/bottleMumps Virus IgG Cut-off Control: 2ml/bottleMumps Virus IgG Negative Control: 2ml/bottle

• 關聯藥證數量: 1

Mumps Virus Coated Wells (IgM): 12 breakapart 8-well snap-off strips coated with MumpsVirus antigen. IgM Sample Diluent: 1 bottle containing 100 ml of buffer for sample dilution.Stop Solution: 1 bottle containing 15 ml sulphuric acid, 0.2 mol/l.Washing Solution (20x conc.): 1 bottle containing 50 ml of a 20-fold concentrated buffer. Mumps Virus anti-IgM Conjugate: 1 bottle containing 20 ml of a peroxidase labeled rabbit antibody to human IgM.TMB Substrate Solution: 1 bottle containing 15 ml TMB.Mumps Virus IgM Positive Control: 2ml/bottleMumps Virus IgM Cut-off Control: 2ml/bottleMumps Virus IgM Negative Control: 2ml/bottle

• 關聯藥證數量: 1

Mupirocin contains not less than 920 μg and not more than 1020 μg of mupirocin (C26H44O9) per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Murine Monoclonal Anti-CA15-3 coated microtiter plate with 96 wells.Sample Diluent, 100 ml.Enzyme Conjugate Concentrate (22X), 1.0 ml.Enzyme Conjugate Diluent, 21 ml.CA15-3 reference standards, containing 0, 15, 30, 60, 120, and 240 Unit/ml. Liquid. 1 set.TMB Reagent (One-Step), 11 ml.Stop Solution (1N HCl), 11 ml.

• 關聯藥證數量: 1

Murine Monoclonal Anti-TSH-coated microtiter wells.\nSet of Reference Standards: 0, 0.5, 2, 5, 10 and 25 μIU/ml, lyophilized.\nEnzyme Conjugate Reagent, 13ml.\nTMB Reagent (One-Step), 11ml.\nStop Solution (1N HCI), 11 ml.

• 關聯藥證數量: 1

Murine Monoclonal anti-CA125 coated microtiter plate with 96 wells.Enzyme Conjugate Reagent, 13 ml.CA125 reference standards containing 0, 15, 50, 100, 200, and 400 Unit/ml of CA125, 1 ml each, ready to use. TMB Reagent (One-Step), 11ml.Stop Solution (1N HC1), 11ml.

• 關聯藥證數量: 1

Murine monoclonal anti-CA 19-9 coated 96 well microtiter plate.\nCA 19-9 reference standards, containing 0, 25, 75, 150, 300, and 600 U/ml CA 19-9, liquid. 1 set.\nCA 19-9 Assay Buffer; 13 ml.\nEnzyme Conjugate Concentrate (12x), 20 ml.\nCA 19-9 Conjugate Diluent, 24 ml.\nWash Buffer Concentrate (20x), 50 ml.\nTMB Reagent (One-Step), 11 ml.\nStop Solution (1N HCl), 11 ml.

• 關聯藥證數量: 1

Murine monoclonal anti-CA19-9 coated 96 well microtiter plate.Assay Buffer,13 ml.Enzyme Conjugate Reagent, 22 ml.CA19-9 reference standards containing 0,15,30,60,120, and 240 U/ml CA19-9, liquid. Ready for use. 1 set.TMB Reagent (One-Step), 11 ml.Stop Solution (1N HCl), 11 ml.

• 關聯藥證數量: 1

Murine monoclonal antibodies against D-dimer labeled with a fluorescent dye and immobilized on the solid phase, and stabilizer.

• 關聯藥證數量: 1

Mycophenolate Mofetil contains 98.0%~102.0% (on dried basis)

• 關聯藥證數量: 1

Mycophenolate mofetil contains not less than 98.0 percent and not more than 102.0 percent of C23H31NO7, calculated on the dried basis.

• 關聯藥證數量: 1

Mycoplasma Pneumoniae Coated Wells (IgA): 12 breakapart 8-well snap-off strips coated with MumpsVirus antigen. IgA Sample Diluent: 1 bottle containing 100 ml of buffer for sample dilution.Stop Solution: 1 bottle containing 15 ml sulphuric acid, 0.2 mol/l.Washing Solution (20x conc.): 1 bottle containing 50 ml of a 20-fold concentrated buffer. Mycoplasma Pneumoniae anti-IgA Conjugate: 1 bottle containing 20 ml of peroxidase labelled rabbit antibody to human IgA.TMB Substrate Solution: 1 bottle containing 15 ml TMB.Mycoplasma Pneumoniae IgA Positive Control: 2ml/bottleMycoplasma Pneumoniae IgA Cut-off Control: 2ml/bottleMycoplasma Pneumoniae IgA Negative Control: 2ml/bottle

• 關聯藥證數量: 1

Mycoplasma Pneumoniae Coated Wells (IgG): 12 breakapart 8-well snap-off strips coated with MumpsVirus antigen. IgG Sample Diluent: 1 bottle containing 100 ml of buffer for sample dilution.Stop Solution: 1 bottle containing 15 ml sulphuric acid, 0.2 mol/l.Washing Solution (20x conc.): 1 bottle containing 50 ml of a 20-fold concentrated buffer. Mycoplasma Pneumoniae anti-IgG Conjugate: 1 bottle containing 20 ml of peroxidase labelled rabbit antibody to human IgG.TMB Substrate Solution: 1 bottle containing 15 ml TMB.Mycoplasma Pneumoniae IgG Positive Control: 2ml/bottleMycoplasma Pneumoniae IgG Cut-off Control: 2ml/bottleMycoplasma Pneumoniae IgG Negative Control: 2ml/bottle

• 關聯藥證數量: 1

Mycoplasma Pneumoniae Coated Wells (IgM): 12 breakapart 8-well snap-off strips coated with MumpsVirus antigen; vacuum sealed, in resealable aluminium foil.\nIgM Sample Diluent ***: 1 bottle containing 100 ml of buffer for sample dilution; pH 7.2 ± 0.2; coloured yellow; ready to use; white cap. \nStop Solution: 1 bottle containing 15 ml sulphuric acid, 0.2 mol/l; ready to use; red cap.\nWashing Solution (20x conc.)*: 1 bottle containing 50 ml of a 20-fold concentrated buffer (pH 7.2 ± 0.2) for washing the wells; white cap.\nMycoplasma Pneumoniae anti-IgM Conjugate**: 1 bottle containing 20 ml of peroxidase labelled rabbit antibody to human IgM; coloured red, ready to use; black cap.\nTMB Substrate Solution: 1 bottle containing 15 ml 3,3,5,5-tetramethylbenzidine (TMB); ready to use; yellow cap.\nMycoplasma Pneumoniae IgM Positive Control***: 1 bottle containing 2 ml; coloured yellow; ready to use; red cap.\nMycoplasma Pneumoniae IgM Cut-off Control***: 1 bottle containing 2 ml; coloured yellow; ready to use; gr

• 關聯藥證數量: 1

Mycoplasma pneumoniae: \n1. Antigen\n2. Postive Control\n3. Negative Control

• 關聯藥證數量: 1

Myoglobin human

• 關聯藥證數量: 1

M： Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5 mL:\n Streptavidin-coated microparticles, 0.72 mg/mL, binding capacity:\n 470 ng biotin/mg microparticles.

• 關聯藥證數量: 1

N ADNase B Reagent consists of lyophilized polystyrene particles coated with antibodies against streptococcal DNase B from rabbits.N ADNase B Standard Serum (human) consists of a mixture of human sera. N ADNase B Control Serum (human) consists of a mixture of human sera. N ADNase B Supplementary Reagent consists of a stabilized streptococcal DNase B solution with the addition of rabbit serum. Preservative:N ADNase B Reagent after reconstitution, N ADNase B Standard Serum, N ADNase B Control Serum and N ADNase B supplementary Reagent: Sodium azide<1g/L

• 關聯藥證數量: 1

N Antisera are liquid animal sera and are porduced by immunization of rabbits with highly purified human fibrinogen.

• 關聯藥證數量: 1

N Antisera are liquid animal sera and are produced by immunization of rabbits with highly purified C1 inhibitor.

• 關聯藥證數量: 1

N Antisera are liquid animals sera and are produced by immunization of rabbits with highly purified human fibrinogen, antithrombin III, plasminogen, or C1 Inhibitor, Labile components are removed from the antisera by a special procedure. Microbial contamination is essentially excluded by filtration and addition of sodium azide as a preservative (<1g/L). After solid phase immunoadsorption, the purified, specific antisera are specially tested and adjusted for optimal suitability for use on the BN* Systems. The antibody titers (T) are determined by radial immunodiffusion and are printed on the vial labels. The titers are indicate the quantity of antigen in mg which will be precipated in an agarose gel by 1 mL of the corresponding antiserum.

• 關聯藥證數量: 1

N Antisera liquid animals sera and are produced by immunization of rabbits with highly purified human fibrinogen, antithrombin III, plasminogen, or C1 Inhibitor, Labile components are removed from the antisera by a special procedure.

• 關聯藥證數量: 1

N Antisera produced by immunization of rabbits with highly purified human ceruloplasmin.

• 關聯藥證數量: 1

N Antisera produced with highly purified human complement factors (C3c or C4)

• 關聯藥證數量: 1

N Antisera, for transferrin liquid animal sera and are produced by immunization of rabbits.

• 關聯藥證數量: 1

N Antiserum to Human Albumin.

• 關聯藥證數量: 1

N Antiserum to Human Apolipoprotein B. Preservative (sodium azide <1 g/L)

• 關聯藥證數量: 1

N Antiserum to Human C3c

• 關聯藥證數量: 1

N Antiserum to Human Immunoglobulin / L-chain κ type.(Rabbits)

• 關聯藥證數量: 1